Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
1(8%)
Results Posted
20%(2 trials)

Phase Distribution

Ph phase_2
1
8%
Ph phase_3
5
42%
Ph phase_1
6
50%

Phase Distribution

6

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
6(50.0%)
Phase 2Efficacy & side effects
1(8.3%)
Phase 3Large-scale testing
5(41.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(10)

Detailed Status

Completed10
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (50.0%)
Phase 21 (8.3%)
Phase 35 (41.7%)

Trials by Status

completed1083%
not_yet_recruiting18%
recruiting18%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT06034743Phase 3

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Completed
NCT07007793Phase 3

A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism

Recruiting
NCT07655362Phase 3

Baxdrostat and Ventricular Remodeling

Not Yet Recruiting
NCT06344104Phase 3

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

Completed
NCT06168409Phase 3

A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension

Completed
NCT06336356Phase 2

A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension

Completed
NCT06194032Phase 1

A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants

Completed
NCT06657105Phase 1

A Study to Investigate the Pharmacokinetics of Ethinyl Estradiol and Levonorgestrel When Given Alone and in Combination With Baxdrostat in Healthy Females of Non-childbearing Potential

Completed
NCT06357520Phase 1

A Study to Investigate the Pharmacokinetics of Baxdrostat When Given Alone and in Combination With Itraconazole in Healthy Participants

Completed
NCT05961384Phase 1

Phase 1 Study to Determine the Metabolism and Clearance of Baxdrostat

Completed
NCT05966324Phase 1

Baxdrostat Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in a Japanese Population

Completed
NCT05961397Phase 1

Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12